124 related articles for article (PubMed ID: 2291867)
1. Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.
Currie D; Lewis RV; McDevitt DG; Nicholson AN; Wright NA
Br J Clin Pharmacol; 1990 Oct; 30(4):527-36. PubMed ID: 2291867
[TBL] [Abstract][Full Text] [Related]
2. Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
Currie D; Lewis RV; McDevitt DG; Nicholson AN; Wright NA
Br J Clin Pharmacol; 1988 Aug; 26(2):121-8. PubMed ID: 2905148
[TBL] [Abstract][Full Text] [Related]
3. Central effects of repeated administration of atenolol and captopril in healthy volunteers.
McDevitt DG; Currie D; Nicholson AN; Wright NA; Zetlein MB
Eur J Clin Pharmacol; 1994; 46(1):23-8. PubMed ID: 8005182
[TBL] [Abstract][Full Text] [Related]
4. Central effects of the diuretic, bendrofluazide.
McDevitt DG; Currie D; Nicholson AN; Wright NA; Zetlein MB
Br J Clin Pharmacol; 1994 Sep; 38(3):249-56. PubMed ID: 7826827
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined atenolol and nifedipine administration on psychomotor performance in normal subjects.
Gerrard L; Wheeldon NM; McDevitt DG
Eur J Clin Pharmacol; 1995; 48(3-4):229-33. PubMed ID: 7589046
[TBL] [Abstract][Full Text] [Related]
6. Central effects of the calcium antagonist, nifedipine.
McDevitt DG; Currie D; Nicholson AN; Wright NA; Zetlein MB
Br J Clin Pharmacol; 1991 Nov; 32(5):541-9. PubMed ID: 1954069
[TBL] [Abstract][Full Text] [Related]
7. Central effects of combined bendrofluazide and atenolol administration. A single dose study in normal subjects.
Gerrard L; Wheeldon NM; McDevitt DG
Eur J Clin Pharmacol; 1993; 45(6):539-43. PubMed ID: 8157039
[TBL] [Abstract][Full Text] [Related]
8. Central effects of the angiotensin-converting enzyme inhibitor, captopril. II. Electroencephalogram and body sway.
Nicholson AN; Wright NA; Zetlein MB; Currie D; McDevitt DG
Br J Clin Pharmacol; 1990 Oct; 30(4):537-46. PubMed ID: 2291868
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
10. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.
Fletcher AE; Bulpitt CJ; Hawkins CM; Havinga TK; ten Berge BS; May JF; Schuurman FH; van der Veur E; Wesseling H
J Hypertens; 1990 May; 8(5):463-6. PubMed ID: 2163421
[TBL] [Abstract][Full Text] [Related]
11. The effects of captopril vs atenolol on memory, information processing and mood: a double-blind crossover study.
Deary IJ; Capewell S; Hajducka C; Muir AL
Br J Clin Pharmacol; 1991 Sep; 32(3):347-53. PubMed ID: 1777372
[TBL] [Abstract][Full Text] [Related]
12. Actions and interactions of psychotropic drugs on human performance and mood: single doses of ORG 3770, amitriptyline, and diazepam.
Mattila M; Mattila MJ; Vrijmoed-de Vries M; Kuitunen T
Pharmacol Toxicol; 1989 Aug; 65(2):81-8. PubMed ID: 2682593
[TBL] [Abstract][Full Text] [Related]
13. Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers.
Ferrara SD; Giorgetti R; Zancaner S; Orlando R; Tagliabracci A; Cavarzeran F; Palatini P
Eur J Clin Pharmacol; 1999 Jan; 54(11):821-7. PubMed ID: 10027654
[TBL] [Abstract][Full Text] [Related]
14. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Paran E; Anson O; Neumann L
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular response to dynamic treadmill exercise in patients with essential hypertension before and after therapy with atenolol or captopril.
Shah PK; Lakhotia M; Chittora M; Mehta S; Mehta S; Vyas R; Parihar M
J Assoc Physicians India; 1990 Oct; 38(10):781-4. PubMed ID: 2084084
[TBL] [Abstract][Full Text] [Related]
16. Effects of atenolol and propranolol on human performance and subjective feelings.
Landauer AA; Pocock DA; Prott FW
Psychopharmacology (Berl); 1979 Jan; 60(2):211-5. PubMed ID: 106432
[TBL] [Abstract][Full Text] [Related]
17. Captopril compared to atenolol in mild to moderate hypertension in a randomized double-blind controlled trial.
Havinga TK; ten Berge BS; May JF; Schuurman FH; van der Veur E; Wesseling H
Neth J Med; 1991 Feb; 38(1-2):13-7. PubMed ID: 2030804
[TBL] [Abstract][Full Text] [Related]
18. Central effects of beta-adrenoceptor antagonists.
Salem SA; McDevitt DG
Clin Pharmacol Ther; 1983 Jan; 33(1):52-7. PubMed ID: 6848299
[TBL] [Abstract][Full Text] [Related]
19. The H1-antagonist mequitazine: studies on performance and visual function.
Nicholson AN; Stone BM
Eur J Clin Pharmacol; 1983; 25(4):563-6. PubMed ID: 6418550
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers.
McClelland GR; Cooper SM; Pilgrim AJ
Br J Clin Pharmacol; 1990 Dec; 30(6):795-803. PubMed ID: 2288826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
